On 2 October, Steven Jordan purchased 6,648 shares in the biotechnology company Genovis, where he is a board member. The shares were purchased at a price of GBP 1.48 per share. The purchase price amounts to GBP 9,839.
This is disclosed in the Swedish Financial Supervisory Authority’s insider register.
The transaction took place outside the trading venue.
